Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers
Open Access
- 28 November 2018
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 16 (12) , 475
Abstract
T-type calcium channel (CaV3.x) blockers are receiving increasing attention as potential therapeutics for the treatment of pathophysiological disorders and diseases, including absence epilepsy, Parkinson’s disease (PD), hypertension, cardiovascular diseases, cancers, and pain. However, few clinically approved CaV3.x blockers are available, and selective pharmacological tools are needed to further unravel the roles of individual CaV3.x subtypes. In this work, through an efficient synthetic route to the marine fungal product pseudellone C, we obtained bisindole alkaloid analogs of pseudellone C with a modified tryptophan moiety and identified two CaV3.2 (2, IC50 = 18.24 µM; 3, IC50 = 6.59 µM) and CaV3.3 (2, IC50 = 7.71 µM; 3, IC50 = 3.81 µM) selective blockers using a FLIPR cell-based assay measuring CaV3.x window currents. Further characterization by whole-cell patch-clamp revealed a preferential block of CaV3.1 activated current (2, IC50 = 5.60 µM; 3, IC50 = 9.91 µM), suggesting their state-dependent block is subtype specific.Keywords
Funding Information
- National Health and Medical Research Council (APP1072113)
This publication has 27 references indexed in Scilit:
- Expression and Pharmacology of Endogenous Cav Channels in SH-SY5Y Human Neuroblastoma CellsPLOS ONE, 2013
- A potent and selective indole N-type calcium channel (Cav2.2) blocker for the treatment of painBioorganic & Medicinal Chemistry Letters, 2011
- Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and AnxietyChemical Reviews, 2010
- The Evolution of Antipsychotic Drug Therapy: Reserpine, Chlorpromazine, and HaloperidolJournal of Psychiatric Practice, 2007
- Validation of High Throughput Screening Assays Against Three Subtypes of Ca v 3 T-Type Channels Using Molecular and Pharmacologic ApproachesASSAY and Drug Development Technologies, 2007
- The pharmacology and regulation of T type calcium channels: New opportunities for unique therapeutics for cancerCell Calcium, 2006
- Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseasesLife Sciences, 2005
- Indolyl Carboxylic Acids by Condensation of Indoles with α-Keto AcidsJournal of Natural Products, 2000
- Tremorgenic Indole Alkaloids Potently Inhibit Smooth Muscle High-Conductance Calcium-Activated Potassium ChannelsBiochemistry, 1994
- Preclinical and Clinical Pharmacology of Vinca AlkaloidsDrugs, 1992